Menu
Back to User profile » Dr Hanmant Barkate
Papers published by Dr Hanmant Barkate:
Efficacy of Super-Bioavailable Itraconazole and Conventional Itraconazole at Different Dosing Regimens in Glabrous Tinea Infection - A Randomized Clinical Trial [Corrigendum]
Shenoy MM, De A, Shah B, Das A, Saraswat A, Lahiri K, Yadav S, Sarda A, Chakraborty D, J D, Kamat S, Doshi Y, Gonsalves N, Choudhary A, Dhoot D, Mahadkar N, Bhushan S, Gadkari R, Barkate H
Drug Design, Development and Therapy 2023, 17:3033-3034
Published Date: 28 September 2023
Efficacy of Super-Bioavailable Itraconazole and Conventional Itraconazole at Different Dosing Regimens in Glabrous Tinea Infection - A Randomized Clinical Trial
Shenoy MM, De A, Shah B, Das A, Saraswat A, Lahiri K, Yadav S, Sarda A, Chakraborty D, J D, Kamat S, Doshi Y, Gonsalves N, Choudhary A, Dhoot D, Mahadkar N, Bhushan S, Gadkari R, Barkate H
Drug Design, Development and Therapy 2023, 17:2899-2908
Published Date: 21 September 2023
Comparative Efficacy of Super Bioavailable Itraconazole Capsules 50 mg vs 65 mg Twice Daily in the Management of Glabrous Tinea
Shah B, Mistry D, Jairam D, Kansara K, Pandya R, Vasani P, Dhoot D, Mahadkar N, Bhushan S, Barkate H
Infection and Drug Resistance 2023, 16:2409-2416
Published Date: 24 April 2023
Patient Satisfaction and Sensory Attributes of Nasal Spray Treatments of Olopatadine Hydrochloride/Mometasone Furoate Monohydrate and Azelastine Hydrochloride/Fluticasone Propionate for Allergic Rhinitis in Australia – An Observational Real-World Clinical Study
Fifer S, Toh L, Barkate H, Aggarwal V, Borade D, Gordonsmith RH, Wu W, Morgan C, Young K
Patient Preference and Adherence 2023, 17:141-151
Published Date: 15 January 2023
Evaluation of the Efficacy and Safety of Apremilast in the Management of Lichen Planus
Viswanath V, Joshi P, Dhakne M, Dhoot D, Mahadkar N, Barkate H
Clinical, Cosmetic and Investigational Dermatology 2022, 15:2593-2600
Published Date: 2 December 2022
Real-World Experience with Favipiravir for the Treatment of Mild-to-Moderate COVID-19 in India
Joshi S, Vora A, Venugopal K, Dadhich P, Daxini A, Bhagat S, Patil S, Barkate H
Pragmatic and Observational Research 2022, 13:33-41
Published Date: 27 May 2022
Evaluation of the Safety and Efficacy of Favipiravir in Adult Indian Patients with Mild-to-Moderate COVID-19 in a Real-World Setting
Reddy PK, Patil S, Khobragade A, Balki A, Raj Aneesh, Kalikar M, Reddy R, Shinde R, CR J, Mutha A, Boyilla N, Rajadhyaksha GC, Karnik N, Bhagat S, Pendse A, Dhage P, Wu W, Rangwala S, Barkate H
International Journal of General Medicine 2022, 15:4551-4563
Published Date: 3 May 2022
An Open-Label, Randomized, Prospective, Comparative, Three-Arm Clinical Trial to Evaluate the Safety and Effectiveness of Apremilast with Three Different Titration Methods in Patients with Chronic Plaque Psoriasis in India
Viswanath V, Joshi P, Lawate P, Tare D, Dhoot D, Mahadkar N, Barkate H
Psoriasis: Targets and Therapy 2022, 12:53-61
Published Date: 22 April 2022
A Comparative, Three-Arm, Randomized Clinical Trial to Evaluate the Effectiveness and Tolerability of Bilastine vs Fexofenadine vs Levocetirizine at the Standard Dose and Bilastine vs Fexofenadine at Higher Than the Standard Dose (Up-Dosing) vs Levocetirizine and Hydroxyzine (in Combination) in Patients with Chronic Spontaneous Urticaria
Shah B, Dhoot D, Choudhary A, Jangid N, Mistry D, Shah S, Kamat S, Barkate H
Clinical, Cosmetic and Investigational Dermatology 2022, 15:261-270
Published Date: 18 February 2022
An Open-Label, Randomized, Double-Arm Clinical Trial to Compare the Effectiveness and Safety of Super Bioavailable Itraconazole Capsules and Itraconazole Capsules in the Management of Dermatophytosis in India
Shenoy M, Dhoot D, Mahajan H, Barkate H
Clinical, Cosmetic and Investigational Dermatology 2021, 14:1367-1376
Published Date: 27 September 2021